Breaking News

Illumina sues Guardant Health; ARPA-H has a bumpy road ahead

 

Cancer Briefing

STAT+: Illumina sues Guardant Health, saying former employees stole trade secrets to launch liquid biopsy firm

By Jonathan Wosen

Adobe

The sequencing giant claims the patents at the core of Guardant’s business are based on confidential information that was stolen.

Read More

STAT+: Biden's agency to 'end cancer as we know it' is finally real. But it has a chaotic road ahead

By Lev Facher

Anna Moneymaker/Getty Images

Congress funded ARPA-H, the agency Biden pledged will help “end cancer as we know it," but left major questions unanswered.

Read More

STAT+: After a dry spell for cancer immunotherapy, a new target offers a beacon of hope

By Angus Chen

Molly Ferguson for STAT

Here’s STAT’s comprehensive guide to the biology behind LAG-3, the buy-in from biopharma companies, and the roadblocks ahead.

Read More

Tuesday, March 22, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments